Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshimasa Tanaka

Showing results (1-10 of 206) with videos related to

Pageof 21
Sort By:
Immunological Reviews|September 5, 2020
Cancer immunotherapy harnessing γδ T cells and programmed death-1Yoshimasa Tanaka
Journal of Clinical and Experimental Hematopathology : JCEH|October 25, 2006
Human gamma delta T cells and tumor immunotherapyYoshimasa Tanaka
Journal of Leukocyte Biology|March 12, 2024
IL-4 within the bone marrow: a key driver of lung tumorigenesisYoshimasa Tanaka
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 25, 2012
[GammadeltaT cell therapy]Yoshimasa Tanaka, Haruki Okamura
Pharmaceuticals (Basel, Switzerland)|February 17, 2015
γδ T Cell Immunotherapy-A ReviewHirohito Kobayashi, Yoshimasa Tanaka
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 11, 2009
[Alterations in immunological responses: conformational changes of allergens and application to hyposensitivity therapy]Seigo Korematsu, Yoshimasa Tanaka
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 20, 2013
[Anti-PD-1 antibody: basics and clinical application]Yoshimasa Tanaka, Haruki Okamura
Methods in Molecular Biology (Clifton, N.J.)|September 8, 2006
The cDNA sequencing projectHideko Urushihara, Takahiro Morio, Yoshimasa Tanaka
International Journal of Molecular Sciences|January 28, 2026
Host Responses to SARS-CoV-2 with an Emphasis on CytokinesHideki Hayashi, Yoshinao Kubo, Yoshimasa Tanaka
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 29, 2010
[New development in breast cancer therapy. III. Zoledronic acid and anti-tumor immunity in breast cancer]Tomoharu Sugie, Yoshimasa Tanaka, Masakazu Toi
Pageof 21

Showing results (1-10 of 206) with videos related to

Sort By:
Pageof 21
Immunological Reviews|September 5, 2020
Cancer immunotherapy harnessing γδ T cells and programmed death-1Yoshimasa Tanaka
Journal of Clinical and Experimental Hematopathology : JCEH|October 25, 2006
Human gamma delta T cells and tumor immunotherapyYoshimasa Tanaka
Journal of Leukocyte Biology|March 12, 2024
IL-4 within the bone marrow: a key driver of lung tumorigenesisYoshimasa Tanaka
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 25, 2012
[GammadeltaT cell therapy]Yoshimasa Tanaka, Haruki Okamura
Pharmaceuticals (Basel, Switzerland)|February 17, 2015
γδ T Cell Immunotherapy-A ReviewHirohito Kobayashi, Yoshimasa Tanaka
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 11, 2009
[Alterations in immunological responses: conformational changes of allergens and application to hyposensitivity therapy]Seigo Korematsu, Yoshimasa Tanaka
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 20, 2013
[Anti-PD-1 antibody: basics and clinical application]Yoshimasa Tanaka, Haruki Okamura
Methods in Molecular Biology (Clifton, N.J.)|September 8, 2006
The cDNA sequencing projectHideko Urushihara, Takahiro Morio, Yoshimasa Tanaka
International Journal of Molecular Sciences|January 28, 2026
Host Responses to SARS-CoV-2 with an Emphasis on CytokinesHideki Hayashi, Yoshinao Kubo, Yoshimasa Tanaka
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 29, 2010
[New development in breast cancer therapy. III. Zoledronic acid and anti-tumor immunity in breast cancer]Tomoharu Sugie, Yoshimasa Tanaka, Masakazu Toi
Pageof 21